The deregulation of G6pc expression thus contributes to several physiological pathologies such as glycogen storage disease type 1a (due to a deficiency in G6pc) [1, 2] or type 2 diabete (due to an overexpression of G6pc) [3, 4] in mammals. This evidence concerns the gene G6PC1 and type 2 diabetes mellitus.